Ann: Investor Presentation, page-2

Liked the presentation of the adjusted results for the 1-year results in this slide deck, that shows myopia progression was slowed 89% by Naturalvue compared to 59% for Misight over the control values.

The adjusted progression for children wearing Naturalvue compared to Misight was even more impressive though - it was on average just -0.06D from the poster presentation. Compare this to the same value for Msight in the table below from their 3-year study:


So, children wearing Naturalvue progressed in myopia OVER 4 TIMES less that those wearing Misight. Also note that the average adjusted value falls into the clinical meaningful range for Misight (> -0.25D), but is well below for Naturalvue.

Doesn't get much more convincing than that for the 1 year results. A much superior product based on these data.

At 2 years, children wearing Misight had progressed by -0.47D on average, almost twice the clinically meaningful progression level of -0.25D. It is possible extrapolating from the 1-yr results for Naturalvue, that after 2 years progression children wearing Naturalvue may not have even reached the clinically meaningful range (as found in the real world data).